Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andre Strydom

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Acta Neuropathologica|July 18, 2024
Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndromeAmal Kasri, Elena Camporesi, Eleni Gkanatsiou, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 10, 2021
Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's diseaseAndrew J Aschenbrenner, R Asaad Baksh, Bessy Benejam, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 14, 2024
Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndromeHampus Hillerstrom, Richard Fisher, Matthew P Janicki, et al.
Journal of Neurodevelopmental Disorders|April 22, 2026
Lifestyle intervention and cognitive outcomes in Down syndrome: a horizon 21 European Down syndrome consortium scoping reviewEimear McGlinchey, Sarah Pape, Shahid H Zaman, et al.
Neuromolecular Medicine|May 5, 2021
Correction to: Specific Susceptibility to COVID-19 in Adults with Down SyndromeTomer Illouz, Arya Biragyn, Milana Frenkel-Morgenstern, et al.
Neuromolecular Medicine|November 19, 2021
Correction to: Specific Susceptibility to COVID-19 in Adults with Down SyndromeTomer Illouz, Arya Biragyn, Milana Frenkel-Morgenstern, et al.
Neuromolecular Medicine|March 4, 2021
Specific Susceptibility to COVID-19 in Adults with Down SyndromeTomer Illouz, Arya Biragyn, Milana Frenkel-Morgenstern, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 1, 2025
The Mental Health Bill (2025) for England and Wales: professional and carer consensus statement summarising concerns and unintended consequences from proposed changes to autism and learning disabilityPeter Beazley, Regi T Alexander, John L Taylor, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
An international survey on the impact of COVID-19 in individuals with Down syndromeAnke Hüls, Alberto C S Costa, Mara Dierssen, et al.
Eclinicalmedicine|March 1, 2021
Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C surveyAnke Hüls, Alberto C S Costa, Mara Dierssen, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Acta Neuropathologica|July 18, 2024
Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndromeAmal Kasri, Elena Camporesi, Eleni Gkanatsiou, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 10, 2021
Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's diseaseAndrew J Aschenbrenner, R Asaad Baksh, Bessy Benejam, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 14, 2024
Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndromeHampus Hillerstrom, Richard Fisher, Matthew P Janicki, et al.
Journal of Neurodevelopmental Disorders|April 22, 2026
Lifestyle intervention and cognitive outcomes in Down syndrome: a horizon 21 European Down syndrome consortium scoping reviewEimear McGlinchey, Sarah Pape, Shahid H Zaman, et al.
Neuromolecular Medicine|May 5, 2021
Correction to: Specific Susceptibility to COVID-19 in Adults with Down SyndromeTomer Illouz, Arya Biragyn, Milana Frenkel-Morgenstern, et al.
Neuromolecular Medicine|November 19, 2021
Correction to: Specific Susceptibility to COVID-19 in Adults with Down SyndromeTomer Illouz, Arya Biragyn, Milana Frenkel-Morgenstern, et al.
Neuromolecular Medicine|March 4, 2021
Specific Susceptibility to COVID-19 in Adults with Down SyndromeTomer Illouz, Arya Biragyn, Milana Frenkel-Morgenstern, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 1, 2025
The Mental Health Bill (2025) for England and Wales: professional and carer consensus statement summarising concerns and unintended consequences from proposed changes to autism and learning disabilityPeter Beazley, Regi T Alexander, John L Taylor, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
An international survey on the impact of COVID-19 in individuals with Down syndromeAnke Hüls, Alberto C S Costa, Mara Dierssen, et al.
Eclinicalmedicine|March 1, 2021
Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C surveyAnke Hüls, Alberto C S Costa, Mara Dierssen, et al.
Pageof 12